SHARx Files Defamation Suit Against AbbVie
AbbVie also named SHARx in a lawsuit in which SHARx is not a defendant, causing SHARx to miss out on a merger that would have increased its national reach and helped reduce prescription expenses for thousands of Americans.
- AbbVie also named SHARx in a lawsuit in which SHARx is not a defendant, causing SHARx to miss out on a merger that would have increased its national reach and helped reduce prescription expenses for thousands of Americans.
- “For six years AbbVie accepted nearly every application our team submitted on behalf of our underinsured members.
- Without ever contacting SHARx, they cut off our patients, disregarding the needs of those who qualify for their program by their own standards,” said SHARx CEO Corey Durbin.
- SHARx provides multiple sourcing options, including the Patient Assistance Programs of companies like AbbVie.